Business
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including 70+ patents and proprietary extraction technologiesLeverages Health Canada Dealer's License and FDA-aligned clinical development pathways, including IND-enabled activitiesPositions the Company at the forefront of the rapidly emerging regulated psychedelic medicine industryAdvances clinical...
About this update from Red Light Holland Corp
[{"type":"list","items":[{"val":[{"type":"text","content":"Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distribution","length":134,"tagName":"p"}]},{"val":[{"type":"text","content":"Adds Filament's extensive intellectual property portfolio, including 70+ patents and proprietary extraction technologies","length":124,"tagName":"p"}]},{"val":[{"type":"text","content":"Leverages Health Canada Dealer's License and FDA-aligned clinical development pathways, including IND-enabled activities","length":124,"tagName":"p"}]},{"val":[{"type":"text","content":"Positions the Company at the forefront of the rapidly emerging regulated psychedelic medicine industry","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Advances clinical pipeline, including PEX010, while expanding access to natural psilocybin products globally","length":108,"tagName":"p"}]},{"val":[{"type":"text","content":"Establishes a regulated pipeline of psychedelic compounds, including ibogaine, MDMA, and psilocybin, supporting next-generation drug discovery and IND-enabled clinical development within compliant frameworks","length":207,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":799,"olType":false},{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce, further to their joint press releases dated March 10, 2026 (the "March 10 Release"), March 23, 2026, April 27, 2026 and April 29, 2026, that effective April 29, 2026, Red Light has acquired all the issued and outstanding common shares of Filament ("Filament Shares"), pursuant to a statutory plan of arrangement (the "Arrangement" or the "Transaction") under the Business Corporations Act (British Columbia). Capitalized terms not otherwise defined herein have the meanings attributed to them in the March 10 Release.","length":811,"tagName":"p"},{"type":"text","content":"With the closing of the Transaction, Red Light has acquired all issued and outstanding Filament Shares, creating a vertically integrated platform focused on the development, commercialization, and global distribution of...